Deletion in the FMR1 gene in a fragile-X male
✍ Scribed by Mannermaa, Arto; Pulkkinen, Leena; Kajanoja, Eliisa; Ryynänen, Markku; Saarikoski, Seppo
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 298 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
✦ Synopsis
The pathogenesis of Fragile-X syndrome is a consequence of absence of the FMRl gene product associated with expansion of the CGG repeat and abnormal methylation of this and a CpG island 250 bp proximal to the CGG repeat located at exon 1 in the FMRl gene. While this is usually the case, some suspected Fragile-X syndrome patients have been described with a mutation other than CGG expansion. W e describe here an affected Fragile-X male, who was found to be mosaic of a full mutation of the CGG expansion and a deletion in the FMRl gene. The patient's phenotype is probably mainly due to the effect of the full mutation of the repeat sequence. Thus, the influence of the deletion is difficult to evaluate.
📜 SIMILAR VOLUMES
The fragile X mental retardation 1 gene (FMR1) mutation is strongly correlated with specific and marked neurobehavioral and neuroanatomical abnormalities. The protein product, FMRP, is highly expressed in neurons of the normal mammalian brain, and absent or in low levels in leukocytes from individua
Several mechanisms can explain the occurrence of full-mutation fragile X males with an I& level above -2 SD below mean, also called "high-functioning fragile X males." Incomplete methylation of the CpG island at the 5' end of the FMRl gene is one of these mechanisms. The present study describes the
The fragile X syndrome phenotype of mental retardation is almost always caused by abnormal CGG trinucleotide amplification within the FMR1 gene. Occasionally fragile X syndrome results from point mutations or deletions within or around the FMR1 locus. We have identified a mentally retarded African A